Atlanta, GANCT06626230Now EnrollingIRB Ready

Anal High Grade Squamous Intraepithelial Lesion Clinical Trial in Atlanta, GA

Access cutting-edge anal high grade squamous intraepithelial lesion treatment through this phase 1 clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.

Sponsored by Lisa Flowers

Quick Self-Assessment

See if you qualify for this Atlanta location

Preparing your pre-screening questions…

Expert Care in Atlanta

Access anal high grade squamous intraepithelial lesion specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related anal high grade squamous intraepithelial lesion treatment provided free

Apply for This Atlanta Location

Check if you qualify for this anal high grade squamous intraepithelial lesion clinical trial in Atlanta, GA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Atlanta

    Convenient for GA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Atlanta site if eligible
  4. 4Begin participation

About This Anal High Grade Squamous Intraepithelial Lesion Study in Atlanta

The purpose of this study is to see if curcumin can reverse anal high-grade squamous intraepithelial lesions (aHSIL) (high-grade anal precancerous cells or high-grade abnormal cells) in people living with HIV to avoid current treatments such as ablation (destroying abnormal cells with heat or surgical excision (cutting out the abnormal cells)), which have potential short- and long-term side effects.

Sponsor: Lisa Flowers

Who Can Participate

Inclusion Criteria

30 and older
Have biopsy-proven anal intraepithelial neoplasia (AIN) 2, AIN 3 without previous treatment
Or cytology results for ASC-H or HSIL
Able and willing to complete Study Diary
Other inclusion criteria apply

Exclusion Criteria

Have a clinically significant chronic medical condition that is considered progressive, such as but not limited to coronary disease, congestive heart failure, chronic obstructive lung disease, and diabetes mellitus. Chronic nonprogressive or intermittent syndromes are not excluded, including migraine headaches, mild reactive airway disease, controlled hypertension, stable pain syndromes, or benign gastric reflux.
Have any history of anal cancer malignancy.
Pregnant or planning to become pregnant in the next three months.
Have a history of sensitivity or allergy to any compound used in this study.
Have Grade 2 or higher renal or hematology abnormality,
Are currently using, or in the last year have used intravenous drugs (except for therapeutic use), recreational drugs, or alcohol abuse.
Other exclusion criteria apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Atlanta?

Yes, this clinical trial (NCT06626230) has an active research site in Atlanta, GA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Anal High Grade Squamous Intraepithelial Lesion Treatment Options in Atlanta, GA

If you're searching for anal high grade squamous intraepithelial lesion treatment options in Atlanta, GA, this clinical trial (NCT06626230) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Atlanta research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced anal high grade squamous intraepithelial lesion specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all anal high grade squamous intraepithelial lesion clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Atlanta, GA

See all alzheimers disease clinical trials recruiting in Atlanta — not just this study.

Browse Alzheimers Disease Trials in Atlanta →

Ready to Join in Atlanta?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Atlanta, GA